Intensive Parent-child Interaction Therapy (I-PCIT): Feasibility and Effectiveness Study.

Overview

About this study

The purpose of this study is to evaluate the feasibility of implementing I-PCIT in a community clinic, measured by treatment attendance and caregiver’s satisfaction compared to the current gold-standard of PCIT-au.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Please contact the study team to discuss whether or not you are eligible to participate in a study.

Inclusion Criteria:

  • Participants in I-PCIT will be enrolled from the outpatient Behavioral Health Clinic in La Crosse WI. PCIT-au group will be a chart review from La Corsse WI and Rochester MN.
  • Children, ages 2-7 years old.
  • Children whose measure of EBP rated above the clinically significant range (T-score ≥ 60) on ECBI.
  • Eligible families will have to commit to a full course of treatment. 
  • Patients who have answered yes to research authorization.
  • Children of patients who have answered yes to research authorization.

Exclusion Criteria: 

  • Children with an intellectual disability, Autistic Disorder, or a psychotic disorder.
  • The inability of parents to attend sessions daily.
  • Patients that answered no to research authorization

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

La Crosse, Wis.

Mayo Clinic principal investigator

Chelsea Ale, Ph.D., L.P.

Open for enrollment

Contact information:

Chelsea Ale Ph.D., L.P.

(608) 392-9555

Ale.Chelsea@mayo.edu

Rochester, Minn.

Mayo Clinic principal investigator

Magdalena Romanowicz, M.D.

Contact us for the latest status

Contact information:

Jennifer Inbarasu M.D.

(507)293-5522

Inbarasu.Jennifer@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20451082

Mayo Clinic Footer